Cleared Traditional

K905288 - ANESTHESIA/RESPIRATORY FACE MASK, VARIOUS SIZES (FDA 510(k) Clearance)

Class I Anesthesiology device.

K905288 · Med-Tek Innovations, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
134d
Days
Class 1
Risk

K905288 is an FDA 510(k) clearance for the ANESTHESIA/RESPIRATORY FACE MASK, VARIOUS SIZES. Classified as Mask, Oxygen (product code BYG), Class I - General Controls.

Submitted by Med-Tek Innovations, Inc. (Glendale, US). The FDA issued a Cleared decision on April 9, 1991 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5580 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Med-Tek Innovations, Inc. devices

Submission Details

510(k) Number K905288 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 1990
Decision Date April 09, 1991
Days to Decision 134 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d faster than avg
Panel avg: 139d · This submission: 134d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code BYG Mask, Oxygen
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 868.5580
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.